STAT3 and lung carcinoma: Both CUR and RES have been found to suppress STAT3 activity, suggesting their potential as therapeutic agents against lung cancer (Yousef, Vlachogiannis, and Tsiani 2017; Wan Mohd Tajuddin et al. 2019; Ashrafizadeh, Najafi, et al. 2020).